Screening-detected and symptomatic untreated celiac children show similar gut microflora-associated characteristics

Bo Tjellström1, Lars Stenhammar, Lotta Högberg

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institut, Stockholm, Sweden. bo.tjellstrom@ki.se

Insights

Children with screening-detected celiac disease (CD) show aberrant gut flora, similar to symptomatic CD. This finding in fecal short-chain fatty acid (SCFA) profiles suggests common disease mechanisms.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pediatrics

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion.
  • Intestinal microflora alterations are implicated in CD pathogenesis.
  • Screening-detected CD represents an early stage of the disease.

Purpose of the Study:

  • To investigate the metabolic function of intestinal microflora in children with screening-detected CD.
  • To compare the gut flora profile of screening-detected CD with symptomatic CD and healthy controls.
  • To determine if aberrant gut flora is present in early-stage CD.

Main Methods:

  • Screening of 912 12-year-old children for CD using serum anti-human tissue transglutaminase-IgA.
  • Analysis of 17 children with biopsy-confirmed CD.
  • Fecal short-chain fatty acid (SCFA) analysis via gas-liquid chromatography.
  • Comparison with previously published data from symptomatic CD and healthy children.

Main Results:

  • Children with screening-detected CD exhibited a fecal SCFA profile similar to those with symptomatic CD.
  • The SCFA profile in screening-detected CD differed significantly from that of healthy children.
  • Aberrant gut microflora metabolic function is present even in early, asymptomatic CD.

Conclusions:

  • This study provides the first evidence of SCFA patterns in fecal samples from children with screening-detected CD.
  • The similar SCFA profiles suggest shared pathogenic mechanisms between screening-detected and symptomatic CD.
  • Findings may inform future therapeutic or prophylactic strategies targeting gut microflora in celiac disease.
Abstract

Related Concept Videos

Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...